Molecular cytogenetic characterization of marginal zone B-cell lymphonia: Correlation with clinicopathologic findings in 14 cases

Haematologica

Volumn 86, Issue 1, 2001, Pages 64-70

  Cuneo, A ^a   Bigoni, R ^a   Roberti, M G ^a   Milani, R ^a   Agostini, P ^a   Cavazzini, F ^a   Minotto, C ^a   De Angeli, C ^a   Bardi, A ^a   Tammiso, E ^a   Negrini, M ^a   Cavazzini, P ^a   Castoldi, G ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

BCL6 rearrangement; Chromosome deletions; Marginal zone B cell lymphoma; Non Hodgkin's lymphoma

Indexed keywords

ALPHA INTERFERON; CARBOPLATIN; CHLORAMBUCIL; CYTARABINE; ETOPOSIDE; FLUDARABINE; MITOXANTRONE; STEROID;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 3Q; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MALE; MOLECULAR GENETICS;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; MALE; MIDDLE AGED;

EID: 0035136387     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Monocytoid B-cell lymphoma. Clinicopatholgic study of 21 cases of a unique type of low-grade lymphoma
2. The histopathology of splenic lymphoma with villous lymphocytes
3. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
4. B-cell lymphoma of MALT type: A review with special emphasis on diagnostic and management problems of low-grade gastric tumors
5. The t(11;18) (q21;q21) chromosome translocation is a frequent and specific aberration in low grade, but not high-grade, malignant non Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT) type
6. The apoptosis inhibitor gene APl2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with MALT lymphomas
7. BCL10 is involved in t(1;14)(p22;q32) of MALT B-cell lymphoma and mutated in multiple tumor types
8. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features
9. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lyrephoid tissue
10. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma
11. Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin
12. Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridation
13. 13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinico-pathological features
14. Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiological features
15. Minimal region of loss at 13q14 in B-CLL
16. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation
17. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
18. Non Hodgkin's lymphomas with t(11;14) (q13;q32): A subset of mantle zone/intermediate lymphocytic lymphoma
19. Genomic organization of the ATM locus involved in ataxia-telangiectasia
20. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization
21. p53 mutations are associated with histologic transformation of follicular lymphoma
22. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin's lymphoma
23. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations
24. Prognostic value of chromosomal abnormalities in follicular lymphoma
25. Splenic marginal zone lymphoma
26. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
27. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: A study by FISH
28. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
29. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma
30. Rearrangement of BCL-6 gene as a prognostic marker in diffuse large-cell lymphoma
31. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma
32. Frequent association of t(3;14) or variant with other lymphoma-specific translocations
33. BCL6 gene rearrangements also occur in marginal zone B-cell lyrephoma
34. Frequent mutation of bcl-6 proto-oncogene in high grade, but not low grade, MALT lymphomas of the gastrointestinal tract
35. Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia
36. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities
37. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype, and morphology
38. Gastric low grade lymphoma, high grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy
39. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
40. Chromosome 11q rearrangements in B non Hodgkin's lymphoma
41. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukemia
42. 11q deletions define a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
43. Acquired deletion of the ataxia teleangiectasia (ATM) locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features
44. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma